Red Flags to Look Out for When Purchasing Exosomes

Buying an exosome or extracellular-vesicle product can be difficult because not every seller provides the same level of transparency.

A professional website, impressive particle count, or scientific-sounding product description doesn't necessarily tell you who manufactured the product, what's actually in the vial, or how it was tested.

Before purchasing, watch for these red flags.

Red Flag #1: No Batch-Specific Certificate of Analysis

One of the biggest warning signs is a seller that cannot provide meaningful documentation for the product being sold.

Ask for a batch-specific Certificate of Analysis (COA).

Ideally, you should be able to follow:

Vial → Lot number → COA → Test results

A generic specification sheet—or a COA from an unrelated batch—isn't the same thing as documentation tied to the lot you're purchasing.

And don't stop at simply seeing a COA. Check what was actually tested.

See How to Read an Exosome Certificate of Analysis.

Red Flag #2: You Can't Figure Out Who Actually Makes It

The company selling an exosome product may be a distributor rather than the manufacturer. That's perfectly normal.

The red flag is when nobody will clearly tell you who the manufacturer is.

Be cautious when a company talks extensively about “our lab,” “our scientists,” or “our manufacturing” but provides little verifiable information about the actual facility producing the product.

Ask:

Who manufactures this? Where is it manufactured?

If those simple questions produce vague answers, keep asking.

Red Flag #3: The Biological Source and Manufacturing Process Are Vague

Extracellular vesicles can come from different biological sources, and understanding that source is an important part of evaluating a product.

Some EV products are produced using cultured cells. In these systems, the cells are grown and expanded before extracellular vesicles are collected from the conditioned culture media. For these products, cell passage history is an important manufacturing consideration.

A passage occurs when cultured cells are transferred and expanded again. As cells undergo repeated rounds of expansion, they can develop changes associated with replicative aging and cellular senescence. Research has shown that these changes can also affect the composition and characteristics of the extracellular vesicles the cells release.

For cultured-cell-derived products, buyers should be able to determine what type of cells are used, their original biological source, how the cells are expanded, whether passage number is monitored and controlled, and what cell-culture controls the manufacturer uses.

Amniotic-fluid-derived products involve a different manufacturing pathway. Rather than producing extracellular vesicles through cultured-cell-conditioned media, the starting material is collected amniotic fluid. In this case, questions about collection, transportation, storage and handling of the source material become particularly important.

According to KWEHEALTH, amniotic fluid used in its clinical-grade manufacturing process is received by the facility within 24 hours of collection. KWEHEALTH distinguishes this from research-grade amniotic fluid that may be stored for later use.

HydroKarma is produced from refined human amniotic fluid obtained from scheduled C-sections. According to KWEHEALTH, its process begins with this collected amniotic fluid rather than cultured-cell-conditioned media.

Whether a product comes from a cultured-cell system or directly collected biological material, the manufacturer should be able to clearly explain the source and how that source material is controlled throughout manufacturing. If a seller cannot provide meaningful information about where the material came from or how it was handled, that deserves additional scrutiny.

For a deeper look at cultured-cell manufacturing, see What Does Cell Passage Number Mean in Exosome Manufacturing?

Red Flag #4: Huge Particle Numbers With Little Explanation

100 billion!

200 billion!

500 billion!

Large numbers are easy to market. What matters is the documentation behind them. Ask:

500 billion what—and measured how?

A number on its own is much more informative alongside the analytical method, particle-size distribution, EV-associated markers, protein measurements and other characterization for the lot being sold.

See How Are Extracellular Vesicle Particle Counts Measured? and 50 Billion vs. 100 Billion Exosomes: Does a Higher Count Mean Better?

Red Flag #5: “Lab Tested” With No Actual Test Results

“Lab tested” sounds impressive.

It also tells you almost nothing by itself.

What was tested?

Look for actual reported results rather than a badge or marketing statement.

Depending on the product documentation, that may include things such as:

particle characterization, EV-associated markers, protein measurements, sterility, endotoxin, cell count, osmolality or particulate matter.

Different tests answer different questions.

The more specific the claim, the easier it should be to determine what evidence supports it.

Red Flag #6: The Vial Itself Carries No Usable Lot Identification

Documentation is only half of traceability. The vial in your hand should carry a lot or batch identifier you can read, along with the product name and expiration or use-by information.

If the label carries no lot identification, you have no way to connect the physical product to any documentation — now or later, if a question comes up after delivery.

Red Flag #7: Nobody Can Explain Storage or Shipping

Ask what happens between manufacturing and delivery.

• Where is the product stored?
• At what temperature?
• Who ships it?
• Is temperature-controlled shipping required?

For products requiring cold-chain handling, vague answers deserve additional scrutiny.

A product's history doesn't stop when manufacturing ends.

Learn more in What Is Cold-Chain Storage and Why Does It Matter?.

Red Flag #8: Packaging That May Not Be Appropriate for the Product

The container holding a biological product is part of the product's overall storage and handling system, so packaging deserves more attention than simply whether a vial looks professional.

Glass is widely used for pharmaceutical and biological products because it can provide strong barrier properties and, when appropriately selected for the formulation, a low risk of interaction with the material it contains. Polymer containers can also be appropriate, but their material compatibility and potential extractables and leachables should be considered when they are used for sensitive biological preparations.

HydroKarma products are supplied in glass vials. The container is an important part of maintaining the integrity of the finished product throughout frozen storage, cold-chain shipping and handling through final use.

What Transparency Looks Like

A trustworthy seller should make it easy to understand what you're buying and where it came from. Product identity, biological source, manufacturer, lot-specific documentation, testing, storage and shipping information should be readily available rather than buried behind vague marketing language.

At Express Biologics, we distribute HydroKarma products manufactured by KWEHEALTH and provide batch-specific documentation and educational resources that help buyers understand the products and the testing behind them.

Transparency isn't about asking customers to simply trust a seller. It's about giving them meaningful information they can examine for themselves.

The Bottom Line

The biggest red flag isn't necessarily one particular number, container or marketing phrase.

It's a lack of transparency.

If you can't determine who made the product, where it came from, which lot you're buying, what testing was performed, or how it was handled, don't let an impressive website or enormous particle count answer those questions for you.